Literature DB >> 4608263

Prophylactic antibiotics in cesarean section.

M Moro, M Andrews.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4608263

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


× No keyword cloud information.
  9 in total

1.  [Comparative efficacy of antibiotic prophylaxis using cefoxitin in one or in three doses in cesarean section].

Authors:  A Masse; P Turgeon; N Gay; G Verschelden
Journal:  CMAJ       Date:  1988-05-15       Impact factor: 8.262

2.  Antimicrobial prophylaxis.

Authors:  R G Positano; N Shafer; P J Lupo
Journal:  J Natl Med Assoc       Date:  1984-07       Impact factor: 1.798

3.  Long vs short-course antibiotic prophylaxis in cesarean section: a comparative clinical study.

Authors:  O Ayangade
Journal:  J Natl Med Assoc       Date:  1979-01       Impact factor: 1.798

4.  Cesarean section: trends and morbidity.

Authors:  T F Baskett; R M McMillen
Journal:  Can Med Assoc J       Date:  1981-10-01       Impact factor: 8.262

5.  Use of a topical antibiotic spray in vaginal surgery.

Authors:  V C Wright; N M Lanning; R Natale
Journal:  Can Med Assoc J       Date:  1978-06-10       Impact factor: 8.262

Review 6.  Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.

Authors:  Fiona M Smaill; Rosalie M Grivell
Journal:  Cochrane Database Syst Rev       Date:  2014-10-28

7.  Rational and irrational use of antibiotics in a Canadian teaching hospital.

Authors:  M R Achong; B A Hauser; J L Krusky
Journal:  Can Med Assoc J       Date:  1977-02-05       Impact factor: 8.262

Review 8.  Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.

Authors:  Fiona M Smaill; Gillian Ml Gyte
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

9.  [Use of cephalosporins as antibiotic prophylaxis in cesarean section].

Authors:  P Fugère; P Turgeon; M Boucher; G Verschelden; M Lemay
Journal:  Can Med Assoc J       Date:  1983-07-15       Impact factor: 8.262

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.